A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 262 participants.

Also called NCT01942070

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 262 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01942070
Other papers using this trial's data
  • Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial European heart journal, 2019-01-07 DOI, PubMed 30520980

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01942070. Randomized; no masking; primary purpose treatment. Start 2013-09 (actual); primary completion 2018-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction
Acronym
ISAR-Absorb MI
Condition
Cardiovascular Disease
Condition
Thrombus
Condition
Primary Angioplasty
Intervention (Device)
Bioresorbable vascular scaffold
Intervention (Device)
Durable polymer everolimus-eluting metallic stent
Lead sponsor
Deutsches Herzzentrum Muenchen (class: other)

Record details

Record id
cardio:ct-nct01942070
Content hash
da45e053b73d0ed485dcac5e6dc33edf8fef4746720c512c4f52474350c11989